Utilization of Tofu By-products as an Alternative Source of Bioactive Peptide Lunasin
2019
- 362Usage
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Usage362
- Downloads209
- Abstract Views153
Artifact Description
Utilization of tofu by-products as an alternative source of bioactive peptide Lunasin Lunasin is a 5kDa water-soluble bioactive peptide present in soybeans with anti-inflammatory, anti-carcinogenic, and chemotherapeutic properties. Current mechanisms for obtaining Lunasin from soybeans involve complicated and expensive methods that limit its utilization to a laboratory scale. Tofu is a cheese-like product obtained from soybeans. Whey and okara are the major by-products of the process and are mainly destined for animal feeding or as ingredients for food preparations, but their potential application as a sources of lunasin remains unexplored. Therefore, the aim of this study was to stablish if tofu by-products are suitable sources for obtaining lunasin enriched material by applying simple and easily scalable methods. Tofu was prepared from soybeans by a standardized procedure, and calcium was used to induce preferential precipitation of lunasin present in the by-products. Precipitate and supernatant fractions were characterized by measuring protein content, protein profile, lunasin content, and presence of isoflavones via Bradford assay, electrophoresis, western blot and HPLC respectively. Liquid fractions showed a wide distribution of proteins while calcium precipitates only contained low molecular weight proteins (<15kDa). Both fractions contain negligible amounts of isoflavones and a significant concentration of lunasin, indicating that tofu by-products can be used as a source of lunasin enriched material.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know